| Tuesday September 14, 2004 |
| 8:30 - 9:00 a.m. |
Continental Breakfast |
| 9:00 - 9:10 a.m. |
Welcome and Overview of Meeting Goals
Robert Riddle, Ph.D.
National Institute on Drug Abuse, NIH |
| The Problem: HCV and the Treatments |
| 9:10 - 9:40 a.m. |
Richard Garfein |
| 9:40 - 10:10 a.m. |
Glenn Randall, Ph.D.
Rockefeller University |
| 10:10 - 10:40 a.m. |
Francis V. Chisari |
| 10:40 - 11:00 a.m. |
Break |
| Progress in Cell Culture and Animal Model Systems |
| 11:00 - 11:30 a.m. |
Judith Lieberman, M.D., Ph.D.
Harvard Medical School |
| 11:30 - 12 Noon |
Mark A. Kay |
| 12 Noon - 1:30 p.m. |
Lunch (on your own) |
| RNAi Technology: Issues of Longevity and Delivery |
| 1:30 - 2:00 p.m. |
Thomas Tuschl |
| 2:00 - 2:30 p.m. |
Thomas Ulich |
| 2:30 - 3:00 p.m. |
David V. Morrissey |
| Potential Problems and Potential Insights |
| 3:00 - 3:30 p.m. |
Bryan R. G. Williams |
| 3:30 - 4:00 p.m. |
Mark Sulkowski |
| 4:00 - 4:15 p.m. |
Break |
| Animal Models |
| 4:15 - 4:45 p.m. |
Robert Lanford |
| 4:45 - 5:15 p.m. |
Norman Kneteman |
| 5:15 p.m. |
Adjournment |
| |
| Wednesday September 15, 2004 |
| 8:30 - 9:00 a.m. |
Continental Breakfast/Registration |
| 9:00 - 11:00 a.m. |
Discussion:
Major Achievements
Major Hurtles
Future Directions For Research Towards Clinical Applications |
| 11:00 a.m. |
Adjournment |
